JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

The Journal of Nuclear Medicine Vol. 6 No. 9 687-689
© 1965 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bolliger, T. T.
Right arrow Articles by Maynard, C. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bolliger, T. T.
Right arrow Articles by Maynard, C. D.

The Demonstration of Extracranial Neoplasms with 99mTc Pertechnetate

Theodore T. Bolliger, M.D., Richard L. Witcofski, M.S., Joseph E. Whitley, M.D. and C. Douglas Maynard, M.D.1,2,3,

Winston-Salem, N. C.

ABSTRACT

Extracranial neoplasms have been visualized by scintiscanning as a result of their selective localization of 99mTc pertechnetate. The initial experience in 11 known neoplasms is presented. Compared with reported results with 197Hg chlormerodrin, 99mTc pertechnetate has the advantages of immediate and rapid scanning; it has the limitation of activity in normal blood pools, as well as in certain abdominal organs.

FOOTNOTES

1 Department of Radiology, Bowman Gray School of Medicine, Winston-Salem, N. C.

2 Partially supported by NIH Grant CRT-5069.

3 Trainee of the American Cancer Society.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1965 by the Society of Nuclear Medicine.